COMP <GO>
MAC vs HR // RETURN ON INVESTED CAPITAL (ROIC)
Macerich Company (NYSE) VS. Healthcare Realty Trust Incorporated (NYSE) • 15-METRIC TALLY: MAC 6
— HR 5
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: HR
LAST: $24.74 (-0.28%) • MKT CAP: $7.04B
roic
-4.10%
LAST: $19.18 (+0.31%) • MKT CAP: $6.47B
roic
-3.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MAC VS. HR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MAC | HR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -4.10% | -3.70% | -0.40 | HR | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 4.00% | 7.34% | -3.34 | HR | /fcf-yield <GO> |
| Operating Margin | -23.70% | -60.00% | +36.30 | MAC | /operating-margins <GO> |
| Net Profit Margin | -19.40% | -60.00% | +40.60 | MAC | /net-margins <GO> |
| Revenue Growth (YoY) | 10.40% | 47.30% | -36.90 | HR | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.73% | 6.23% | -3.50 | HR | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 8/9 | -1.00 | HR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.8 | 65.7 | +2.10 | MAC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.05 | 1.02 | +0.03 | MAC | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.0x | 34.0x | -8.00 | MAC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.04B | $6.47B | $562.2M | MAC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MAC REV | HR REV | MAC GROSS % | HR GROSS % | MAC FCF | HR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.01B | $28.2M | — | — | $276.0M | $455.8M |
| FY 2024 | $918.2M | $19.2M | — | — | $242.1M | $500.8M |
| FY 2023 | $884.1M | $17.5M | — | — | $255.7M | $499.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MAC // BETA 1.05
HR // BETA 1.02